Dr Reddys Laboratories (RDY) Retained Earnings (2014 - 2026)

Dr Reddys Laboratories' Retained Earnings history runs 13 years deep, the most recent figure standing at $3.9 billion for Q1 2026.

• In Q1 2026, Retained Earnings rose 8279.63% year-over-year to $3.9 billion; the TTM figure through Mar 2026 stood at $3.9 billion (up 8279.63% YoY), while the FY2026 annual figure was $42.0 million, down 10.64% from the prior year.
• Retained Earnings was $3.9 billion for Q1 2026 at Dr Reddys Laboratories, down from $3.9 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $3.9 billion in Q3 2025 to a low of $45.8 million in Q1 2022.
• Historically, Retained Earnings has averaged $2.4 billion across 5 years, with a median of $2.8 billion in 2023.
• The sharpest annual moves came in 2022 and 2026: Retained Earnings sank 47.22% in 2022, then soared 8279.63% in 2026.
• A 5-year view of Retained Earnings shows it stood at $2.4 billion in 2022, then increased by 18.33% to $2.9 billion in 2023, then rose by 18.15% to $3.4 billion in 2024, then advanced by 13.7% to $3.9 billion in 2025, then slipped by 0.54% to $3.9 billion in 2026.
• The last three Retained Earnings figures came in at $3.9 billion (Q1 2026), $3.9 billion (Q3 2025), and $45.9 million (Q1 2025), per Business Quant data.